News
Centre leading international discussion on harm reduction
Vancouver, March 23,2006
Recent international recognition highlights the Centre is taking a leadership role in harm-reduction research and evaluation.
Montaner named president of international AIDS organization
Vancouver, February 22,2006
Dr. Julio Montaner, Director of the B.C. Centre for Excellence in HIV/AIDS, has been appointed president-elect of the world's leading independent association of HIV/AIDS professionals.
Supervised injection site not increasing rates of drug relapse or discouraging those wishing to stop injecting
Vancouver, January 30,2006
The benefits of Vancouver’s pilot supervised injection site have not been offset by negative impacts on drug use in the community, reveals a new study authored by the B.C. Centre for Excellence in HIV/AIDS.
Four HIV patients to begin receiving experimental drugs TMC 114 and TMC 125
Vancouver, January 11,2006
Four HIV-positive patients will begin treatment comprising experimental drugs TMC 114 and TMC 125 as early as tomorrow, the B.C. Centre for Excellence in HIV/AIDS announced today.
Media releases
Centre leading international discussion on harm reduction
Vancouver, March 23,2006
Recent international recognition highlights the Centre is taking a leadership role in harm-reduction research and evaluation.
Montaner named president of international AIDS organization
Vancouver, February 22,2006
Dr. Julio Montaner, Director of the B.C. Centre for Excellence in HIV/AIDS, has been appointed president-elect of the world's leading independent association of HIV/AIDS professionals.
Supervised injection site not increasing rates of drug relapse or discouraging those wishing to stop injecting
Vancouver, January 30,2006
The benefits of Vancouver’s pilot supervised injection site have not been offset by negative impacts on drug use in the community, reveals a new study authored by the B.C. Centre for Excellence in HIV/AIDS.
Four HIV patients to begin receiving experimental drugs TMC 114 and TMC 125
Vancouver, January 11,2006
Four HIV-positive patients will begin treatment comprising experimental drugs TMC 114 and TMC 125 as early as tomorrow, the B.C. Centre for Excellence in HIV/AIDS announced today.
